Respiratory system

China Medical University Hospital (CMUH) Developing iDREAM to Detect Sleep Apnea at Home

Retrieved on: 
Saturday, March 30, 2024
Quanta, Cloud, Diagnosis, Sleep, UPPP, Sleep apnea, Certification, Sudden death, Intracerebral hemorrhage, Otorhinolaryngology, Patient, Heart rate, Stroke, Research, AI, Record, Snoring, Society, OSAS, Hospital, Electroencephalography, Automation, Hypertension, Respiratory system, Family, Food, Physician, ECG, Apnea, Pharmaceutical industry

TAICHUNG, March 30, 2024 /PRNewswire/ -- Snoring can be an alarming sign of obstructive sleep apnea syndrome (OSAS). Studies showed that 50% of individuals who snore may experience sleep apnea, which can lead to life-threatening conditions such as heart disease, hypertension, intracerebral hemorrhage, stroke, and even sudden death during night-time in severe cases. Sleep Medicine Center at China Medical University Hospital (CMUH, Taiwan) has introduced iDREAM (Intelligent Detection of Respiratory Events through Automated Monitoring), incorporating Quanta's QOCA Portable ECG Monitoring Device, as a simple solution to efficiently detect symptoms of apnea patients during their sleep at home. More than 100 patients have been in clinical trials of iDREAM. With this AI-powered ECG analysis, CMUH's physicians are able to identify obstructive sleep apnea syndrome (OSAS) more accurately and to reduce the time spent for diagnosis and treatment.

Key Points: 
  • Sleep Medicine Center at China Medical University Hospital (CMUH, Taiwan) has introduced iDREAM (Intelligent Detection of Respiratory Events through Automated Monitoring), incorporating Quanta's QOCA Portable ECG Monitoring Device, as a simple solution to efficiently detect symptoms of apnea patients during their sleep at home.
  • With this AI-powered ECG analysis, CMUH's physicians are able to identify obstructive sleep apnea syndrome (OSAS) more accurately and to reduce the time spent for diagnosis and treatment.
  • iDREAM , the home-based sleep detection system, detects ECG change from OSAS episodes and determines severity using its deep learning methodology.
  • It demonstrates 92.7% and 93.2% accuracy for sleep apnea and wake-up events (interruption of sleep from apnea), and 95.8% accuracy for defining severe OSAS (30 episodes per hour).

Press release - Parliament backs tighter EU rules for toy safety

Retrieved on: 
Wednesday, April 3, 2024
Health, CRM, Artificial Intelligence Act, EPP, Per- and polyfluoroalkyl substances, Safety, Mental health, Disruptor (video game), Reproduction, Parliament, Commission, Respiratory system, SME, Hygiene, Privacy, Artificial intelligence

On Wednesday, Parliament approved its position on revamped EU rules on toy safety with 603 votes in favour, 5 against and 15 abstentions.

Key Points: 
  • On Wednesday, Parliament approved its position on revamped EU rules on toy safety with 603 votes in favour, 5 against and 15 abstentions.
  • The rules also target chemicals that are toxic to specific organs or are persistent, bioaccumulative, and toxic.
  • Strengthening checks
    All toys sold in the EU will have to have a digital product passport (replacing the EU declaration of conformity), detailing compliance with the relevant safety rules.
  • Safety, security and privacy by design
    Toys with digital elements need to comply with safety, security and privacy by design standards.

Herbal medicinal product: Foeniculi dulcis fructusArray, F: Assessment finalised

Retrieved on: 
Tuesday, March 12, 2024
Key, Collection, Fungus, Allergy, European Commission, Capsule, Woman, Committee, Respiratory system, Cramp, Mucus, Growth, Rat, Skin, Pregnancy, Date, Seed, Mouth, Lactation, Urinary system, Safety, Fennel, Civil service commission, Common, Rabbit, Fruit, Medicine, Diagnosis, Tablet, Community, Herbal medicine, Spice

Herbal medicinal product: Foeniculi dulcis fructusArray, F: Assessment finalised

Key Points: 


Herbal medicinal product: Foeniculi dulcis fructusArray, F: Assessment finalised

Alen Air Purifiers are Transforming Home Health to Fight Rising Indoor Air Quality Dangers

Retrieved on: 
Thursday, March 7, 2024
Residential Building & Real Estate, Consumer Electronics, Technology, Construction & Property, Health, General Health, Specialty, Retail, Family, Home Goods, Consumer, Pet, Air pollution, Soot, Atmosphere, Alen, Dander, Ammonia, Respiratory system, Volatile organic compound, DVM, Natural gas, Carbon monoxide, Dizziness, Asthma, Harvard University, NO2, HEPA, Allergy, Risk, Atmosphere of Earth, Saliva, Benzene, Cleaning, Nitrogen dioxide, Death, Spore, Headache, EPA, Allergen, Urine, Organic compound, Ventilation, Pollen, AAFA, Human, Methane

The company’s education campaign focuses on pervasive health risks associated with poor indoor air quality.

Key Points: 
  • The company’s education campaign focuses on pervasive health risks associated with poor indoor air quality.
  • “The dangers of poor indoor air quality are not just invisible – they silently jeopardize our health, amplifying the risk of respiratory issues, allergies and long-term health complications,” said Alen CEO, Warburg Lee.
  • Alen air purifiers with HEPA fresh filtration capture fine particles, including ash, soot and VOCs, effectively removing them from the indoor air and reducing exposure to harmful pollutants and allergens like pollen, pet dander, and mold spores, providing symptom relief and improving overall indoor air quality.
  • Addressing these sources of indoor air pollution typically involves implementing strategies such as improving ventilation, using air purifiers with HEPA filters like Alen, and reducing or eliminating the use of products with harmful chemicals.

Press release - MEPs back stricter rules to ensure children’s toys are safe

Retrieved on: 
Tuesday, February 13, 2024
EPP, Internet, Mental health, Consumer Protection Committee, Artificial intelligence, European single market, Respiratory system, AI, Risk management, Safety, Digital, Artificial Intelligence Act, SME, CRM, Privacy, Child, Parliament, Disruptor (video game), Commission, Reproduction, Medical device

Ban on harmful chemicals

Key Points: 
  • Ban on harmful chemicals
    To improve child health protection, the regulation continues to prohibit carcinogenic and mutagenic substances or substances toxic for reproduction (CRM).
  • The adopted text additionally bans chemicals harmful to the endocrine or the respiratory system, and toxic to specific organs.
  • Strengthening checks
    The draft rules provide for manufacturers to create digital product passports for each toy, which detail how it complies with the relevant rules.
  • Background
    Despite the EU market being among the safest in the world, dangerous toys still find their way into consumers’ hands.

Born Free USA Applauds the Introduction of Bill to End Mink Farming in Illinois; Urges Swift Passage

Retrieved on: 
Wednesday, February 7, 2024
Pandemic, State legislature (United States), COVID-19, Public, H5N1, Mortality, Human, Illinois Senate, Safety, Senate, Mink, Global health, State, Respiratory system, Health, Farm, Infection

WASHINGTON, Feb. 7, 2024 /PRNewswire/ -- Born Free USA , a leading wildlife nonprofit, applauds the introduction of Mink Facility Disease Prevention Act (S.B.

Key Points: 
  • WASHINGTON, Feb. 7, 2024 /PRNewswire/ -- Born Free USA , a leading wildlife nonprofit, applauds the introduction of Mink Facility Disease Prevention Act (S.B.
  • Sponsored by State Senate Assistant Majority Leader Linda Holmes, this bill would ban mink fur farming in the state of Illinois to protect public health.
  • Says Angela Grimes, Born Free USA CEO, "The COVID-19 pandemic has shown us that fur farming is harmful to human health and safety.
  • Born Free USA calls on the Illinois legislature to act quickly to pass the bill into law.

CWCI Analyzes California Workers’ Comp Inpatient Care

Retrieved on: 
Wednesday, January 31, 2024
Public Policy, Government, Insurance, Human Resources, State, Local, Managed Care, Surgery, Health, Professional Services, California Department, Manager, MDC, Connective tissue, Care Act 2014, Diagnosis, COVID, Human, Pregnancy, Nervous system, Inpatient care, HCAI, Respiratory system, Medi-Cal, Affordable Care Act, Knee, Hospital

A new analysis by the California Workers’ Compensation Institute (CWCI) uses data on 28.7 million inpatient hospital stays with 2012 through 2022 discharge dates compiled by the California Department of Health Care Access and Information (HCAI) to measure and compare the use of inpatient services and procedures covered by workers’ compensation, Medicare, Medi-Cal and private coverage.

Key Points: 
  • A new analysis by the California Workers’ Compensation Institute (CWCI) uses data on 28.7 million inpatient hospital stays with 2012 through 2022 discharge dates compiled by the California Department of Health Care Access and Information (HCAI) to measure and compare the use of inpatient services and procedures covered by workers’ compensation, Medicare, Medi-Cal and private coverage.
  • The most recent data suggest that many of those factors continue to help contain the volume of workers’ comp inpatient stays, as unlike the other systems where inpatient hospitalizations have rebounded after falling sharply in 2020 (the first year of the pandemic), workers’ comp inpatient stays have continued to drop.
  • With the recent decline in COVID-related hospitalizations, the distribution of workers’ comp inpatient stays by diagnosis shifted back toward pre-pandemic levels.
  • CWCI has issued a Research Update Report on its study, “Utilization of Inpatient Care in California Workers’ Compensation, 2012-2022.” CWCI members and subscribers can access the report and a summary Bulletin at www.cwci.org .

Global Ultrasonic Nebulizer Market to Reach US$ 325.6 Million by 2030, Rising at a CAGR of 5.9% | Report by CoherentMI

Retrieved on: 
Tuesday, January 16, 2024
Cystic fibrosis, World Health Organization, Patient, Chronic obstructive pulmonary disease, Research, Incidence, Hospital, Inhalation, Agilent Technologies, U22, Ultrasound, Asthma, Administration, Growth, Quality of life, Respiratory system, WHO, Health, Omron, Particle size, Prevalence, Pharmaceutical industry

Among the end users, hospitals and clinics are expected to dominate the global ultrasonic nebulizer market.

Key Points: 
  • Among the end users, hospitals and clinics are expected to dominate the global ultrasonic nebulizer market.
  • Key players operating in the global ultrasonic nebulizer market include Philips Healthcare, Omron, PARI Medical, BD, and Agilent Technologies, among others.
  • Large-volume ultrasonic nebulizers are expected to dominate the global ultrasonic nebulizer market in terms of product type.
  • Overall, the global ultrasonic nebulizer market offers lucrative opportunities in large-volume nebulizers for COPD treatment and the growing demand for home healthcare solutions.

Global Ultrasonic Nebulizer Market to Reach US$ 325.6 Million by 2030, Rising at a CAGR of 5.9% | Report by CoherentMI

Retrieved on: 
Tuesday, January 16, 2024
Cystic fibrosis, World Health Organization, Patient, Chronic obstructive pulmonary disease, Research, Incidence, Hospital, Inhalation, Agilent Technologies, U22, Ultrasound, Asthma, Administration, Growth, Quality of life, Respiratory system, WHO, Health, Omron, Particle size, Prevalence, Pharmaceutical industry

Among the end users, hospitals and clinics are expected to dominate the global ultrasonic nebulizer market.

Key Points: 
  • Among the end users, hospitals and clinics are expected to dominate the global ultrasonic nebulizer market.
  • Key players operating in the global ultrasonic nebulizer market include Philips Healthcare, Omron, PARI Medical, BD, and Agilent Technologies, among others.
  • Large-volume ultrasonic nebulizers are expected to dominate the global ultrasonic nebulizer market in terms of product type.
  • Overall, the global ultrasonic nebulizer market offers lucrative opportunities in large-volume nebulizers for COPD treatment and the growing demand for home healthcare solutions.

RSV, flu and COVID: demystifying the triple epidemic of respiratory viruses

Retrieved on: 
Tuesday, January 16, 2024
Mortality, Bronchiolitis, Patient, Research, Infection, Pneumonia, Hospital, Incidence, Health, Wheeze, Fatigue, COVID, Vaccination, Respiratory system, Disease, Immunodeficiency, Pandemic, Aerosol, COVID-19, Virus, Population, Season, Pregnancy, Atmosphere, Immunity, Vaccine, Periodic breathing, SARS-CoV-2, RSV

Since 2022, a triple epidemic of respiratory viruses — RSV, influenza and SARS-CoV-2 — has been disrupting our daily lives. In addition, the media constantly reminds us of how this is straining emergency departments. How does the present respiratory virus season differ from seasons during the pre-COVID era? As a specialist in virus-host interaction, I would like to shed some light on the new dynamics of the respiratory virus season.The infamous SARS-CoV-2Despite limited access to screening tests, analysis of the number of hospital admissions shows that the virus is still going strong.

Key Points: 


Since 2022, a triple epidemic of respiratory viruses — RSV, influenza and SARS-CoV-2 — has been disrupting our daily lives. In addition, the media constantly reminds us of how this is straining emergency departments. How does the present respiratory virus season differ from seasons during the pre-COVID era? As a specialist in virus-host interaction, I would like to shed some light on the new dynamics of the respiratory virus season.

The infamous SARS-CoV-2

  • Despite limited access to screening tests, analysis of the number of hospital admissions shows that the virus is still going strong.
  • It has a strikingly efficient capacity to spread through aerosols, especially as we take refuge indoors to escape the cold.

Resurgence of seasonal flu

  • After a hiatus due to health measures, the influenza virus, which causes seasonal flu, has returned with the same force.
  • It is once again circulating in different variants belonging to Types (strains) A and B, although scientists believe that one Type B strain, the Yamagata lineage, has disappeared.

And what about RSV?

  • Bronchiolitis is characterized by the obstruction of the small airways, which can progress to wheezing or respiratory distress.
  • But RSV also severely affects the elderly and adults who are immunocompromised or have existing chronic conditions.
  • Admittedly, although these three viruses are attracting attention, other less publicized respiratory viruses are also circulating, demonstrating a diverse viral environment.

SARS-CoV-2 has turned everything upside down

  • The challenge is amplified by the extremely high transmission capacity of SARS-CoV-2 compared with influenza and RSV, which makes seasonal management much more complex.
  • But today, the picture has become even more complex with the continuing presence of SARS-CoV-2.

Beyond infection

  • In addition, it causes long-term consequences after infection, such as post-COVID syndrome (also known as long COVID), which affects millions of people.
  • The extent of the consequences of infection and reinfection on human health remains uncertain, as does the effectiveness of vaccines in limiting these effects.

The importance of vaccines

  • The final distinction from the pre-pandemic period is the arrival of RSV vaccines.
  • However, these two vaccines have not yet been officially recommended.
  • The trio of vaccines against COVID-19, influenza and RSV will certainly help to reduce the severe symptoms associated with respiratory virus infections in the coming seasons.


Nathalie Grandvaux received research funding from the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), the Fonds de recherche du Québec - Santé (FRQS), the Canada Foundation for Innovation (CFI), the Fondation du centre hospitalier de l'Université de Montréal, and the Ministère de l'économie et de l'innovation du Québec.